AVEO Pharmaceuticals Investor Relations Material
Latest events
Q2 2022
AVEO Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AVEO Pharmaceuticals Inc
Access all reports
AVEO Pharmaceuticals Inc. was a biopharmaceutical company focused on the development and commercialization of oncology therapeutics. The company engaged in clinical research and regulatory advancement of targeted cancer treatments. It served healthcare providers and patients in the oncology sector. The company was headquartered in Boston, Massachusetts, and its shares were listed on the NASDAQ.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
AVEO
Country
🇺🇸 United States